Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × labetuzumab × Clear all

NCT00041639 2021-08-19

Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms